RapidTherapeutic Science Laboratories, Inc. (OTC: RTSL) manufactures and marketsFDA-listed pressurized metered dose inhalers (pMDIs) that enable users toconveniently and safely self-administer CBD.

RTSL's MDIs deliver a 98% bioavailable dose of CBD each & every time andcould very well replace vape pens, tanks and mods and have a major impact on a$9 Billion market.